Gazyva (obinutuzumab) - Roche, Biogen
Noninflammatory Lupus Vasculopathy Presenting as AKI in Systemic Lupus Erythematosus (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0443; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received steroid taper and obinutuzumab (1g x2, 2 weeks apart)...Renal biopsy demonstrating severe arteriolar hyalinosis and downstream glomerular hypoperfusion (PAS, 200X). Immune deposits staining for IgG and C1q along the vascular walls (immunofluorescence 200X)." 
Gastroenterology • Gastrointestinal Disorder • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4550234
 
Sebastian Hinojosa; Ashima Chadha; Alcino Gama; Claire Avillach; Gearoid M. McMahon; David B. Mount
 
Oct 2, 2026
 
Prev Next